Is McKesson Corporation (MCK) overvalued or fairly valued?

MarketChacha shows McKesson Corporation's valuation in context — a forward P/E of about 16.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of McKesson Corporation (MCK)?

McKesson Corporation last traded at $823.23 (-0.7% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

McKesson Corporation

MCK · NYSE · Healthcare · United States

$823.23-0.7%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:40 PM

Snapshot

TickerMCK

ExchangeNYSE

SectorHealthcare

IndustryMedical Distribution

CountryUnited States

Employees41,600

HeadquartersIrving, United States

Market cap$96.4B

Volume278.66K

Websitewww.mckesson.com

Filings tracked0

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.1%
Institutions95.4%
Public & other4.6%

2,663 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.9.75%
Vanguard Capital Management LLC6.80%
State Street Corporation4.90%
FMR, LLC3.08%
JPMORGAN CHASE & CO2.79%
Franklin Resources, Inc.2.62%
Massachusetts Financial Services Co.2.48%
Geode Capital Management, LLC2.48%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $110.0B · EPS 10.76

Est. earnings growth +9.1%

Next fiscal year

Rev $463.5B · EPS 50.34

Est. earnings growth +13.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$637.0052-wk range$999.00

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about MCK

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.